The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: Report from a National Consensus Conference
Conti F et al. Rheumatology (Oxford) 2018; 57 (Suppl 7): key209. doi: 10.1093/rheumatology/key209
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.